GlaxoSmithKline and Merck KGaA have struck an immunotherapy deal worth up to $4 billion
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Merck KGaA wins GSK for immunotherapy deal worth up to $4.2 billionGlaxoSmithKline bolstered its cancer drug development pipeline on Tuesday, agree...
Baca lebih lajut »
Stocks making the biggest moves premarket: Viacom, Centene, Merck, Alphabet & moreSome of the names on the move ahead of the open.
Baca lebih lajut »
Merck named the best pharma stock by Bank of AmericaBank of America named Merck its top pick among the many U.S. pharmaceutical stocks thanks to the growing success of its key cancer drug.
Baca lebih lajut »
Stocks making the biggest moves premarket: Amazon, Merck, Cigna, Honeywell & moreSome of the names on the move ahead of the open.
Baca lebih lajut »
Stocks making the biggest moves midday: Amazon, Merck, Exxon Mobil & moreThese are the stocks posting the largest moves midday Friday.
Baca lebih lajut »
Merck KGaA wins GSK for immunotherapy deal worth up to $4.2 billionGlaxoSmithKline bolstered its cancer drug development pipeline on Tuesday, agree...
Baca lebih lajut »